Swedish team discovers protein that could fight obesity
A team of researchers in Sweden has discovered a protein that stimulates the formation of fat cells, a finding that could potentially be used to treat obesity, the Karolinska Institute said Wednesday.
The protein, called TRAP (tartrate-resistant acid phosphatase), "stimulates the formation of new fat cells and can thus precipitate the development of obesity," the Institute said in a statement.
The research was based on cell cultures and mice studies, and showed that patients with obesity have excessive levels of the protein.
"This protein is potentially useful in the treatment of conditions involving morbid cachexia (weight loss), such as cancer diseases," said professor Göran Andersson, who led the study.
"The discovery can also lead to new ways of treating obesity based on the inhibition of this protein's effect," he added.
The study lasted four years and followed 14 obese women, Andersson told AFP. The results were published Wednesday in the US online journal Public Library of Science.
Comments
See Also
The protein, called TRAP (tartrate-resistant acid phosphatase), "stimulates the formation of new fat cells and can thus precipitate the development of obesity," the Institute said in a statement.
The research was based on cell cultures and mice studies, and showed that patients with obesity have excessive levels of the protein.
"This protein is potentially useful in the treatment of conditions involving morbid cachexia (weight loss), such as cancer diseases," said professor Göran Andersson, who led the study.
"The discovery can also lead to new ways of treating obesity based on the inhibition of this protein's effect," he added.
The study lasted four years and followed 14 obese women, Andersson told AFP. The results were published Wednesday in the US online journal Public Library of Science.
Join the conversation in our comments section below. Share your own views and experience and if you have a question or suggestion for our journalists then email us at [email protected].
Please keep comments civil, constructive and on topic – and make sure to read our terms of use before getting involved.
Please log in here to leave a comment.